デフォルト表紙
市場調査レポート
商品コード
1609732

日本の3D細胞培養市場レポート:製品、用途、エンドユーザー、地域別、2025年~2033年

Japan 3D Cell Culture Market Report by Product, Application, End User, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 122 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
日本の3D細胞培養市場レポート:製品、用途、エンドユーザー、地域別、2025年~2033年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 122 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の3D細胞培養市場の市場規模は2024年に1億5,200万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに5億2,200万米ドルに達し、2025年から2033年にかけて14.7%の成長率(CAGR)を示すと予測しています。同市場は、創薬、疾患研究、再生医療におけるより正確なin vitroモデルへの需要によって牽引されており、国内の製薬、バイオテクノロジー、研究機関からの強い支持を受けています。

本レポートで扱う主な質問

  • 日本の3D細胞培養市場のこれまでの業績と、今後数年間の業績は?
  • COVID-19の日本の3D細胞培養市場への影響は?
  • 日本の3D細胞培養市場の製品別の内訳は?
  • 日本の3D細胞培養市場の用途別の内訳は?
  • 日本の3D細胞培養市場のエンドユーザー別の内訳は?
  • 日本の3D細胞培養市場のバリューチェーンにはどのような段階がありますか?
  • 日本の3D細胞培養における主な促進要因と課題は何か?
  • 日本の3D細胞培養市場の構造と主要プレーヤーは?
  • 日本の3D細胞培養市場における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の3D細胞培養市場:イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の3D細胞培養市場情勢

  • 過去および現在の市場動向(2019年~2024年)
  • 市場予測(2025-2033)

第6章 日本の3D細胞培養市場:製品別の内訳

  • スキャフォルドベースのプラットフォーム
  • スキャフォルドフリーのプラットフォーム
  • マイクロチップ
  • バイオリアクター
  • その他

第7章 日本の3D細胞培養市場:用途別の内訳

  • がん研究
  • 幹細胞研究
  • 創薬
  • 再生医療
  • その他

第8章 日本の3D細胞培養市場:エンドユーザー別の内訳

  • バイオテクノロジーおよび製薬企業
  • 受託研究機関
  • 学術機関
  • その他

第9章 日本の3D細胞培養市場:競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の3D細胞培養市場:業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第12章 付録

目次
Product Code: SR112024A17974

Japan 3D cell culture market size reached USD 152 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 522 Million by 2033, exhibiting a growth rate (CAGR) of 14.7% during 2025-2033. The market is driven by the demand for more accurate in vitro models in drug discovery, disease research, and regenerative medicine, with strong support from the country's pharmaceutical, biotechnology, and research institutions.

3D cell culture is a revolutionary technique in cell biology and tissue engineering that seeks to replicate the natural three-dimensional environment in which cells grow and interact within the human body. Unlike traditional two-dimensional cell cultures, where cells are typically grown on flat surfaces like petri dishes or culture plates, 3D cell culture systems allow cells to proliferate and behave in a more physiologically relevant manner. This approach involves creating a three-dimensional scaffold or matrix that mimics the extracellular matrix found in tissues. Cells are then seeded into this matrix, allowing them to organize and interact in a manner more closely resembling their behavior in living organisms. 3D cell culture has numerous applications in drug discovery, disease modeling, regenerative medicine, and studying cell behavior in a more biologically accurate context. It provides researchers with a valuable tool to better understand complex cell-cell interactions, tissue development, and disease progression, ultimately leading to more effective therapeutic interventions and a deeper understanding of cellular biology.

Japan 3D Cell Culture Market Trends:

The Japan 3D cell culture market is a rapidly growing and dynamic sector within the country's life sciences and biotechnology landscape. As a key leader in technological innovation and research, Japan has been at the forefront of advancing 3D cell culture technologies and applications. This market's growth is driven by several key factors, including the need for more physiologically relevant in vitro models for drug discovery and development, as well as the study of disease mechanisms. Japanese pharmaceutical and biotechnology companies, as well as research institutions, are actively embracing 3D cell culture to enhance their research capabilities. The technology offers significant advantages by providing a more accurate representation of cellular behavior, tissue development, and drug responses, compared to traditional 2D cell culture methods. With the country's focus on regenerative medicine and precision medicine, the Japan 3D cell culture market is expected to continue its expansion, playing a pivotal role in advancing healthcare research, drug testing, and personalized medicine.

Japan 3D Cell Culture Market Segmentation:

Product Insights:

  • Scaffold-Based Platforms
  • Scaffold-Free Platforms
  • Microchips
  • Bioreactors
  • Others

Application Insights:

  • Cancer Research
  • Stem Cell Research
  • Drug Discovery
  • Regenerative Medicine
  • Others

End User Insights:

  • Biotechnology and Pharmaceutical Companies
  • Contract Research Laboratories
  • Academic Institutes
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan 3D cell culture market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan 3D cell culture market?
  • What is the breakup of the Japan 3D cell culture market on the basis of product?
  • What is the breakup of the Japan 3D cell culture market on the basis of application?
  • What is the breakup of the Japan 3D cell culture market on the basis of end user?
  • What are the various stages in the value chain of the Japan 3D cell culture market?
  • What are the key driving factors and challenges in the Japan 3D cell culture?
  • What is the structure of the Japan 3D cell culture market and who are the key players?
  • What is the degree of competition in the Japan 3D cell culture market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan 3D Cell Culture Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan 3D Cell Culture Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan 3D Cell Culture Market - Breakup by Product

  • 6.1 Scaffold-Based Platforms
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Scaffold-Free Platforms
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Microchips
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Bioreactors
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2019-2024)
    • 6.5.2 Market Forecast (2025-2033)

7 Japan 3D Cell Culture Market - Breakup by Application

  • 7.1 Cancer Research
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Stem Cell Research
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Drug Discovery
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Regenerative Medicine
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2019-2024)
    • 7.5.2 Market Forecast (2025-2033)

8 Japan 3D Cell Culture Market - Breakup by End User

  • 8.1 Biotechnology and Pharmaceutical Companies
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Contract Research Laboratories
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Academic Institutes
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Others
    • 8.4.1 Historical and Current Market Trends (2019-2024)
    • 8.4.2 Market Forecast (2025-2033)

9 Japan 3D Cell Culture Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan 3D Cell Culture Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix